These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24914849)

  • 41. Tumor lesion diameter on diffusion weighted magnetic resonance imaging could help predict insignificant prostate cancer in patients eligible for active surveillance: preliminary analysis.
    Lee DH; Koo KC; Lee SH; Rha KH; Choi YD; Hong SJ; Chung BH
    J Urol; 2013 Oct; 190(4):1213-7. PubMed ID: 23727188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative effectiveness research in localized prostate cancer treatment.
    Hoffman RM; Penson DF; Zietman AL; Barry MJ
    J Comp Eff Res; 2013 Nov; 2(6):583-93. PubMed ID: 24236797
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low-risk prostate cancer patient: active treatment.
    Moul JW; Saad F
    Can J Urol; 2005 Jun; 12 Suppl 2():25-7. PubMed ID: 16018829
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer.
    Welty CJ; Cowan JE; Nguyen H; Shinohara K; Perez N; Greene KL; Chan JM; Meng MV; Simko JP; Cooperberg MR; Carroll PR
    J Urol; 2015 Mar; 193(3):807-11. PubMed ID: 25261803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conventional treatments of localized prostate cancer.
    Zerbib M; Zelefsky MJ; Higano CS; Carroll PR
    Urology; 2008 Dec; 72(6 Suppl):S25-35. PubMed ID: 19095125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option.
    O'Callaghan C; Dryden T; Hyatt A; Brooker J; Burney S; Wootten AC; White A; Frydenberg M; Murphy D; Williams S; Schofield P
    Psychooncology; 2014 Dec; 23(12):1391-8. PubMed ID: 24830805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Active surveillance: the Canadian experience.
    Klotz L
    Curr Opin Urol; 2012 May; 22(3):222-30. PubMed ID: 22453335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Active surveillance in prostate cancer and quality of life].
    Dominguez Escrig JL; Romero R
    Arch Esp Urol; 2014 Jun; 67(5):487-94. PubMed ID: 24914848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A negative confirmatory biopsy among men on active surveillance for prostate cancer does not protect them from histologic grade progression.
    Wong LM; Alibhai SM; Trottier G; Timilshina N; Van der Kwast T; Zlotta A; Lawrentschuk N; Kulkarni G; Hamilton R; Ferrara S; Margel D; Trachtenberg J; Jewett MA; Toi A; Evans A; Fleshner NE; Finelli A
    Eur Urol; 2014 Sep; 66(3):406-13. PubMed ID: 23664820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer.
    Aizer AA; Paly JJ; Zietman AL; Nguyen PL; Beard CJ; Rao SK; Kaplan ID; Niemierko A; Hirsch MS; Wu CL; Olumi AF; Michaelson MD; D'Amico AV; Efstathiou JA
    J Clin Oncol; 2012 Sep; 30(25):3071-6. PubMed ID: 22851571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Watchful waiting versus active surveillance: appropriate patient selection.
    Dall'Era MA; Kane CJ
    Curr Urol Rep; 2008 May; 9(3):211-6. PubMed ID: 18765115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Active surveillance for prostate cancer: selection criteria, guidelines, and outcomes.
    Walker CH; Marchetti KA; Singhal U; Morgan TM
    World J Urol; 2022 Jan; 40(1):35-42. PubMed ID: 33655428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decision-Making in Prostate Cancer – Choosing Active Surveillance Over Other Treatment Options: A Literature Review.
    Bayliss DR; Duff J; Stricker P; Walker K
    Urol Nurs; 2017; 37(1):15-22. PubMed ID: 29240360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist.
    Montironi R; Hammond EH; Lin DW; Gore JL; Srigley JR; Samaratunga H; Egevad L; Rubin MA; Nacey J; Klotz L; Sandler H; Zietman AL; Holden S; Humphrey PA; Evans AJ; Delahunt B; McKenney JK; Berney D; Wheeler TM; Chinnaiyan A; True L; Knudsen B; Epstein JI; Amin MB; ; ;
    Virchows Arch; 2014 Dec; 465(6):623-8. PubMed ID: 25316188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The ongoing need for improved risk stratification and monitoring for those on active surveillance for early stage prostate cancer.
    Welty CJ; Carroll PR
    Eur Urol; 2014 Jun; 65(6):1032-3. PubMed ID: 24636678
    [No Abstract]   [Full Text] [Related]  

  • 56. Active Surveillance of Prostate Cancer in a Community Practice: How to Measure, Manage, and Improve?
    Gaylis F; Cohen E; Calabrese R; Prime H; Dato P; Kane CJ
    Urology; 2016 Jul; 93():60-7. PubMed ID: 26876460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How will focal therapy fit in with existing treatments?
    Emberton M; Gómez-Veiga F; Ahmed H; Dickinson L
    Actas Urol Esp; 2013; 37(10):597-602. PubMed ID: 23870479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Wellbeing during Active Surveillance for localised prostate cancer: a systematic review of psychological morbidity and quality of life.
    Carter G; Clover K; Britton B; Mitchell AJ; White M; McLeod N; Denham J; Lambert SD
    Cancer Treat Rev; 2015 Jan; 41(1):46-60. PubMed ID: 25467109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Words of wisdom. Re: Medium-term outcomes of active surveillance for localized prostate cancer.
    Mir MC; Stephenson AJ
    Eur Urol; 2013 Dec; 64(6):1013-4. PubMed ID: 24209447
    [No Abstract]   [Full Text] [Related]  

  • 60. Defining the role of surveillance in the management of localized prostate cancer.
    Palmer JS; Chodak GW
    Urol Clin North Am; 1996 Nov; 23(4):551-6. PubMed ID: 8948410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.